Development of pharmacophore similarity-based quantitative activity hypothesis and its applicability domain: Applied on a diverse data-set of HIV-1 integrase inhibitors

Journal of Biomolecular Structure and Dynamics

Volumn 33, Issue 4, 2015, Pages 706-722

  Kumar, Sivakumar Prasanth ^a   Jasrai, Yogesh T ^a   Mehta, Vijay P ^a   Pandya, Himanshu A ^a  

^a GUJARAT UNIVERSITY   (India)

Author keywords

distance based pharmacophoric descriptors; HIV 1 integrase inhibitors; MCS based alignment; Pharmacophore similarity; pharmacophore space; quantitative pharmacophore hypothesis

Indexed keywords

INTEGRASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOTHESIS; MOLECULAR MODEL; PHARMACOPHORE; PREDICTION; SUPPORT VECTOR MACHINE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG DEVELOPMENT; MACHINE LEARNING; MOLECULAR MIMICRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

DRUG DISCOVERY; HIV INTEGRASE INHIBITORS; MACHINE LEARNING; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84922255177     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2014.908142     Document Type: Article

References (40)

1. Barnard, J. M., Downs, G. M., Willett, P. (1998). Chemical similarity searching. Journal of Chemical Information and Computer Sciences, 38, 983-996.
2. Batten, L., Bohun, C. S., Cheng, K., Doman, T., Drew, J., Edwards, R., Wood, K. L. (1999). Classification of chemical compound pharmacophore structures. Proceedings of the third PIMS Industrial Problem Solving Workshop, University of Victoria. Retrieved from http://faculty.uoit.ca/bohun/pubs/searle.pdf
3. Bonachéra, F., Horvath, D. (2008). Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships. Journal of Chemical Information and Modeling, 48, 409-425
4. Catalyst. (2000), Catalyst (ver 4.6). San Diego, CA: Accelrys Inc. Retrieved from, http://www.accelrys.com
5. Cato, S. J. (2000). Exploring pharmacophores with Chem-X. In O. F. Guner. (Ed.), Pharmacophore perception, development, and use in drug design (pp 107-126). La Jolla, CA: International University Line
6. Chang, C. C., Lin, C. J. (2001). LIBSVM: A library for support vector machines. Retrieved from http://www.csie.ntu.edu.tw/~cjlin/papers/libsvm.pdf
7. Clement, O. A., Mehl, A. T. (2000). HipHop: Pharmacophore based on multiple common-feature alignment. In O. F. Guner. (Ed.), Pharmacophore perception, development, and use in drug design (pp. 69-84). La Jolla, CA: International University Line.
8. Cramer, R. D., Patterson, D. E., Bunce, J. D. (1988). Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. Journal of the American Chemical Society, 110, 5959-5967
9. Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20, 647-671
10. Dror, O., Shulman-Peleg, A., Nussinov, R., Wolfson, H. J. (2004). Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design. Current Medicinal Chemistry, 11, 71-90
11. Duan, Y., Wu, C., Chowdhury, S., Lee, M. C., Xiong, G., Zhang, W.,., Kollman, P. (2003). A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Journal of Computational Chemistry, 24, 1999-2012
12. Gardiner, E. J. (2013). Graph applications in chemoinformatics and structural bioinformatics. In Information Resources Management Association, USA. (Ed.), Bioinformatics: Concepts, methodologies, tools, and applications (pp. 1126-1157). Hershey, PA: IGI Global.
13. Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T.,., Davies, D. R. (1999). Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proceedings of the National Academy of Sciences, 96, 13040-13043
14. Guner, O. F. (Ed.). (2000). Pharmacophore perception, development, and use in drug design. La Jolla, CA: International University Line.
15. Haigh, J. A., Pickup, B. T., Grant, J. A., Nicholls, A. (2005). Small molecule shape-fingerprints. Journal of Chemical Information and Modeling, 45, 673-684
16. Hsu, C. W., Chang, C. C., Lin, C. J. (2003). A practical guide to support vector classification. Taiwan: Department of Computer Science and Information Engineering, National Taiwan University.
17. Kirchmair, J., Laggner, C., Wolber, G., Langer, T. (2005). Comparative analysis of protein-bound ligand conformations with respect to catalysts conformational space subsampling algorithms. Journal of Chemical Information and Modeling, 45, 422-430
18. Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A., Vriend, G. (2004). Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins: Structure, Function, and Bioinformatics, 57, 678-683
19. Kumar, S. P., Jasrai, Y. T., Pandya, H. A., George, L. B., Patel, S. K. (2013). Structural insights into the theoretical model of Plasmodium falciparum NADH dehydrogenase and its interaction with artemisinin and derivatives: Towards global health therapeutics. OMICS: A Journal of Integrative Biology, 17, 231-241
20. Kumar, S. P., Jasrai, Y. T., Pandya, H. A., Rawal, R. M. (2013). Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2013.849618.
21. Kumar, S. P., Pandya, H. A., Desai, V. H., Jasrai, Y. T. (2014). Compound prioritization from inverse docking experiment using receptor-centric and ligand-centric methods: A case study on Plasmodium falciparum Fab enzymes. Journal of Molecular Recognition, 27, 215-229
22. Laggner, C., Schieferer, C., Fiechtner, B., Poles, G., Hoffmann, R. D., Glossmann, H.,., Moebius, F. F. (2005). Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening. Journal of Medicinal Chemistry, 48, 4754-4764
23. Lemmen, C., Lengauer, T. (2000). Computational methods for the structural alignment of molecules. Journal of Computer-Aided Molecular Design, 14, 215-232
24. Li, H., Sutter, J., Hoffmann, R. (2000). HypoGen: An automated system of generating 3D predictive pharmacophore models. In O. F. Guner. (Ed.), pharmacophore perception, development, and use in drug design (pp. 171-189). La Jolla, CA: International University Line
25. Multiple MCS program. (2010). US: Tripod, NIH. Retrieved from http://tripod.nih.gov/ws/mcs/mcs.jnlp
26. Mustata, G. I., Brigob, A., Briggsa, J. M. (2004). HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. Bioorganic & Medicinal Chemistry Letters, 14, 1447-1454.
27. Patel, Y., Gillet, V. J., Bravi, G., Leach, A. R. (2002). A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP. Journal of Computer-Aided Molecular Design, 16, 653-681
28. Purohit, R., Rajasekaran, R., Sudandiradoss, C., George Priya Doss, C., Ramanathan, K., Rao, S. (2008). Studies on flexibility and binding affinity of Asp25 of HIV-1 protease mutants. International Journal of Biological Macromolecules, 42, 386-391
29. Purohit, R., Rajendran, V., Sethumadhavan, R. (2011). Studies on adaptability of binding residues flap region of TMC-114 resistance HIV-1 protease mutants. Journal of Biomolecular Structure and Dynamics, 29, 137-152
30. Purohit, R., Sethumadhavan, R. (2009). Structural basis for the resilience of Darunavir (TMC114) resistance major flap mutations of HIV-1 protease. Interdisciplinary Sciences: Computational Life Sciences, 1, 320-328
31. Schneidman-Duhovny, D., Dror, O., Inbar, Y., Nussinov, R., Wolfson, H. J. (2008). PharmaGist: A webserver for ligand-based pharmacophore detection. Nucleic Acids Research, 36, W223-W228
32. SPSS Inc. (2007). SPSS for Windows (16.0). Chicago, IL: IBM Corporation.
33. Steindl, T., Laggner, C., Langer, T. (2005). Human rhinovirus 3C protease: Generation of pharmacophore models for peptidic and nonpeptidic inhibitors and their application in virtual screening. Journal of Chemical Information and Modeling, 45, 716-724
34. Van Drie, J. H. (2003). Pharmacophore discovery-Lessons learned. Current Pharmaceutical Design, 9, 1649-1664
35. VLifeMDS: Molecular Design Suite. (2010). Pune: VLife Sciences Technologies. Retrieved from www.vlifesciences.com
36. Wermuth, C. G., Ganellin, C. R., Lindberg, P., Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1997). Annual Reports in Medicinal Chemistry, 33, 385-395
37. Wermuth, C. G., Langer, T. (1993). Pharmacophore identication. In H. Kubinyi. (Ed.), 3D QSAR in drug design: Theory, methods and applications (pp. 117-136). Leiden: ESCOM.
38. Wolber, G., Dornhofer, A. A., Langer, T. (2006). Efficient overlay of small organic molecules using 3D pharmacophores. Journal of Computer Aided Molecular Design, 20, 773-788.
39. Wolber, G., Seidel, T., Bendix, F., Langer, T. (2008). Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discovery Today, 13, 23-29
40. Zhang, S., Golbraikh, A., Oloff, S., Kohn, H., Tropsha, A. (2006). A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models. Journal of Chemical Information and Modeling, 46, 1984-1995